Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia

    August 2013 in “ Journal of pharmaceutical sciences ”
    Carolina Gonçalves Pupe, Flávia Almada do Carmo, Valéria Pereira de Sousa … Lúcio Mendes Cabral
    Studysummary This study found that a transdermal delivery system using 3% azone and P407 gel may enhance the skin permeation of doxazosin and finasteride for treating benign prostatic hyperplasia.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jpharmsci.org →
    Discuss this study in the Community →

    Research cited in this study 1

    1. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia The New England Journal of Medicine · 2003

    Related research 2

    1. The Impact of COVID-19 on the Menstrual Cycle: A General Perspective Brazilian Journal of Health Review · 2023
    2. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia The New England Journal of Medicine · 2003